Skip to main content

Table 4 Patient’s clinical characteristics on the day of infection (D0) and PCT kinetics the next 6 days after diagnosis of CRBSI

From: Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study

 

Controlled

Not controlled

P

 

n = 16

n = 10

 

WBC count [103/μl; mean (SD)]

15.69 (6.9)

14.87 (4.5)

0.745a

CRP [mg/dl; median (IQR)]

15.78 (10.06-21.05)

15.65 (10.55-25.75)

0.732c

SOFA score [mean (SD)]

6.56 (2.19)

8.20 (3.22)

0.135a

Shock [no (%)]

7 (43.8)

7 (70.0)

0.191b

PCT [ng/mL; median (IQR)]

D0 (16/10) d

7.55 (2.50-13.67)

8.30 (2.07-11.35)

0.771c

D + 1 (16/10) d

2.50 (1.53-10.52)

3.00 (1.30-5.55)

0.635c

D + 2 (16/10) d

1.75 (0.65-5.22)

2.70 (1.22-4.27)

0.635c

D + 3 (16/10) d

0.55 (0.50-3.10)

2.60 (0.75-5.12)

0.047c

D + 4 (16/10) d

0.50 (0.23-2.15)

2.40 (0.67-6.00)

0.042c

D + 5 (16/10) d

0.20 (0.13-0.72)

2.40 (0.35-8.17)

0.009c

D + 6 (16/9) d

0.20 (0.12-0.50)

2.10 (0.20-12.25)

0.012c

ΔPCTD0, D+1

−2.65 (−8.90 to −0.75)

−4.60 (−5.63 to −0.78)

0.895c

ΔPCTD+1, D+2

−1.65 (−5.45 to −0.38)

−0.30 (−1.30 to −0.08)

0.037c

ΔPCTD+2, D+3

−1.00 (−2.68 to −0.15)

−0.05 (−0.45 to 0.25)

0.017c

ΔPCTD+3, D+4

−0.15 (−1.65 to −0.03)

−0.15 (−0.28 to 0.73)

0.253c

ΔPCTD+4, D+5

−0.25 (−0.68 to −0.12)

−0.10 (−0.33 to 0.75)

0.085c

ΔPCTD+5, D+6

0.00 (−0.10 to 0.08)

0.00 (−0.45 to 0.20)

0.872c

  1. a Student’s t test; b Chi-square test; c Mann–Whitney test; d No of patients available for analysis (Controlled/Not controlled).